Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,752 | 546 | 98.7% |
| Education | $99.99 | 3 | 0.9% |
| Consulting Fee | $36.56 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,407 | 80 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,383 | 71 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $997.52 | 39 | $0 (2024) |
| CSL Behring | $788.88 | 38 | $0 (2024) |
| Shire North American Group Inc | $686.83 | 39 | $0 (2019) |
| Grifols USA, LLC | $645.16 | 31 | $0 (2024) |
| GENZYME CORPORATION | $631.17 | 31 | $0 (2024) |
| Covis Pharma GmBH | $610.87 | 34 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $509.90 | 27 | $0 (2024) |
| Pharming Healthcare, Inc. | $400.86 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,969 | 88 | Takeda Pharmaceuticals U.S.A., Inc. ($341.72) |
| 2023 | $1,744 | 83 | GlaxoSmithKline, LLC. ($306.01) |
| 2022 | $1,716 | 85 | AstraZeneca Pharmaceuticals LP ($342.88) |
| 2021 | $1,719 | 89 | Covis Pharma GmBH ($374.30) |
| 2020 | $599.16 | 29 | Takeda Pharmaceuticals U.S.A., Inc. ($110.37) |
| 2019 | $945.51 | 49 | AstraZeneca Pharmaceuticals LP ($296.02) |
| 2018 | $1,147 | 69 | CSL Behring ($257.07) |
| 2017 | $1,049 | 58 | Shire North American Group Inc ($408.27) |
All Payment Transactions
550 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | PFIZER INC. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Immunology and Neurology | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.51 | General |
| Category: Hematology/Oncology | ||||||
| 10/17/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: BIOLOGIC | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Immunology | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Immunology | ||||||
| 10/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 09/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 566 | 5,912 | $248,631 | $56,262 |
| 2022 | 19 | 675 | 6,697 | $257,082 | $57,976 |
| 2021 | 20 | 927 | 6,009 | $249,600 | $69,617 |
| 2020 | 15 | 574 | 5,710 | $221,497 | $50,007 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 74 | 1,867 | $80,490 | $19,395 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 132 | 195 | $32,240 | $11,970 | 37.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 72 | 836 | $36,292 | $6,413 | 17.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 28 | 1,636 | $29,448 | $4,145 | 14.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 384 | $28,800 | $3,782 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 28 | $7,000 | $2,486 | 35.5% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 26 | 294 | $6,332 | $1,705 | 26.9% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 34 | 226 | $8,588 | $1,529 | 17.8% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 35 | 50 | $5,590 | $1,170 | 20.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 27 | $3,375 | $998.93 | 29.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,760 | $941.16 | 34.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,280 | $661.23 | 29.0% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 33 | 45 | $2,700 | $560.15 | 20.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 19 | 32 | $1,530 | $294.74 | 19.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 268 | $1,206 | $209.41 | 17.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 67 | 1,698 | $67,920 | $17,439 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 189 | $29,485 | $10,940 | 37.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 39 | 2,420 | $43,974 | $6,027 | 13.7% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 64 | 747 | $32,442 | $5,274 | 16.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 420 | $31,500 | $4,006 | 12.7% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 35 | 390 | $7,800 | $2,331 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 27 | $6,470 | $2,231 | 34.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 40 | $4,820 | $1,486 | 30.8% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 42 | 287 | $10,906 | $1,468 | 13.5% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 43 | 66 | $6,760 | $1,412 | 20.9% |
About Dr. Theodore Lee, MD
Dr. Theodore Lee, MD is a Allergy healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689606881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodore Lee, MD has received a total of $10,889 in payments from pharmaceutical and medical device companies, with $1,969 received in 2024. These payments were reported across 550 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($10,752).
As a Medicare-enrolled provider, Lee has provided services to 2,742 Medicare beneficiaries, totaling 24,328 services with total Medicare billing of $233,861. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Allergy
- Location Atlanta, GA
- Active Since 07/07/2006
- Last Updated 04/06/2012
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1689606881
Products in Payments
- CUVITRU (Biological) $1,207
- NUCALA (Biological) $727.60
- DUPIXENT (Biological) $711.50
- ALVESCO (Drug) $702.10
- TEZSPIRE (Biological) $587.54
- FASENRA (Drug) $554.52
- Hizentra (Biological) $466.79
- FASENRA (Biological) $419.75
- Xembify (Biological) $418.80
- TRELEGY ELLIPTA (Drug) $416.77
- RUCONEST (Biological) $400.86
- XOLAIR (Biological) $389.39
- Haegarda (Biological) $302.15
- Xolair (Biological) $296.64
- CUTAQUIG (Biological) $230.60
- TAKHZYRO (Biological) $227.11
- Quzyttir (Drug) $210.92
- ORLADEYO (Drug) $173.93
- Xhance (Drug) $169.04
- HYQVIA (Biological) $151.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.